May 2019 Briefing – Cardiology
Physician's Weekly,
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2019.
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2019.
Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2019.
(HealthDay)—No significant difference in outcomes was observed in children and adolescents with fragile X syndrome (FXS…
(HealthDay News) -- No significant difference in outcomes was observed in children and adolescents with fragile X syndrome (FXS…
-- No significant difference in outcomes was observed in children and adolescents with fragile X syndrome (FXS) receiving…
In the largest non-pharmacological trial ever in children with fragile X syndrome (FXS), UC Davis researchers found that large-sc…
UC Davis study is largest non-pharmacological trial for fragile X Article ID: 711386 Source Newsroom: UC Davis MIND Institute…